TRVI
Trevi Therapeutics Inc
Price:  
13.45 
USD
Volume:  
720,082.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TRVI Stock Forecast & Price Target

TRVI Stock Price Forecast

The average stock forecast for Trevi Therapeutics Inc (TRVI) in the next 12 months is 24.40 USD. This price target corresponds to an upside of 81.38%. The range of stock forecasts for TRVI is 19.19 - 31.50 USD. Based on the ratings of 17 analysts, the consensus recommendation for TRVI is BUY.
Target Low Average Median High
Price (USD) 19.19 24.40 24.48 31.50
Upside 42.68% 81.38% 82.01% 134.20%

Recommendation Trends

The latest consensus rating for TRVI is "BUY". This is the average recommendation of 17 analysts: 0 strong sell, 0 sell, 1 hold, 10 buy, 6 strong buy. In the previous period, 18 analysts also majorly recommmended "BUY" for TRVI.

TRVI Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
-M
from -M
EPS This Year
-0.47
55.50%
from -0.30
EPS Next Year
-0.57
22.71%
from -0.47